Fed Dissenters Object to Rate Cut Signal Citing Uncertainty Over Next Move Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds Social Security Strategy Weighing Early Claiming and Survivor Benefits at Age 62 Qualcomms Stock Surge Signals Rising Investor Confidence in AIDriven Device Revolution BlockCon Punta Cana to Explore Convergence of Web3 iGaming and Finance at Global Business Retreat SP Global Upgrades RTX Outlook Amid Sustained Aerospace Sector Rebound HBIO Q1 2026 Earnings EPS Surprises to the Upside Despite Challenging Quarter ACU Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges SPRU Q1 2026 Earnings EPS Loss of 016 Per Share No Revenue Disclosed Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Quiet Revenue Disclosure PCT Q1 2026 Earnings Narrowerthanexpected loss amid continued polypropylene recycling progress GOOG Q1 2026 Earnings EPS Misses Estimates Amid Continued AI Investment FGBIP Preferred Shares Hold Steady Yield Support Amid Tight Trading Range CPS Technologies Surges Over 11 Breakout Testing Key Resistance at 13 AZZ Inc AZZ Holds Steady Near Support as Neutral Trading Continues GEN Restaurant Group GENK Faces Selling Pressure Approaches Key Support Level Silicon Laboratories Inc SLAB Notches Modest Gain Amid Semiconductor Sector Tailwinds Plus500 Reports 11 Revenue Growth Reaffirms FullYear Guidance Seaport Entertainment Group Inc SEG Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Catheter Precision VTAK Narrows Trading Range With Modest Decline of 011 as Key Support Holds Kaixin Holdings KXIN Surges Nearly 5 Whats Driving the Momentum Alamo Group ALG Climbs 171 as Shares Approach Key Resistance AUTL Flatlines at 168 Autolus Therapeutics Consolidates Near Key Support TPG Mortgage Investment Trust MITT Consolidates Near 763 as Support and Resistance Levels Hold Cambium Networks CMBM Holds Steady at 040 Key Levels in Focus TransCode Therapeutics RNAZ Gains Over 2 as Biotech Stock Tests Key Resistance Levels CanFite Biopharma CANF Faces Continued Pressure Support Levels in Focus